-
Nov 16, 2016News from SfNAccess PDFs of abstracts from this year's meeting or download them to your e-reader or mobile device.
-
Nov 16, 2016News from SfNMore than 30,300 people attended this year's meeting. If you lost an item, visit the Sails Pavilion today or contact the San Diego Convention Center.
-
Nov 16, 2016Press ReleaseResearch released today reveals new discoveries about the pathology, development, and potential treatments for Alzheimer’s disease. New studies in humans and animal models highlight factors that both contribute to and offer protection from the neurological disorder. The findings were presented at Neuroscience 2016, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
-
Nov 16, 2016Press ReleaseStudies released today reveal new understanding of autism spectrum disorder, outlining potential causes and mechanisms behind the disease and highlighting novel treatment strategies promoting social behavior. The findings were presented at Neuroscience 2016, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
-
Nov 15, 2016News from SfNSfN supports and welcomes free exchange of ideas, diversity, and global collaboration »
-
Nov 15, 2016News from SfNDon’t miss out on today’s Public Advocacy Forum »
-
Nov 15, 2016News from SfNSee demonstrations, compare products, and save time by placing orders while you’re in San Diego.
-
Nov 15, 2016Press ReleaseAdvances in technology and increased understanding of the properties of neurons are paving the way for future neuroscience breakthroughs. Researchers are both improving common techniques in efforts to make treatments safer and refine animal models, as well as creating novel ways to stimulate and map the brain.
-
Nov 15, 2016Press ReleaseResearch released today reveals new strategies for treating chronic pain, post-traumatic stress disorder, and alcohol abuse by targeting the brain’s cannabinoid system. Targeting cannabinoid receptors — which bind both natural neurotransmitters and the psychoactive ingredient in marijuana — may provide some of the therapeutic benefits of marijuana without the side effects. The findings were presented at Neuroscience 2016, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
-
Nov 15, 2016Press ReleaseResearch released today highlights the role of alpha-synuclein, a protein that accumulates and spreads in the brains of Parkinson’s disease patients over time, offering new insights into the onset, physiology, and treatment options for the disease. The studies were presented at Neuroscience 2016, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
Quick Links
Copyright ©
Society for Neuroscience